Self-funded PhD opportunity

Investigation of the diversity and role of rhamnosyltransferase enzymes in rhamnolipid synthesis in bacteria.

Subject: Biomedical Sciences


Summary

Rhamnolipids have been identified as microbial biosurfactants with huge potential for industrial exploitation, however, the best known producer, Pseudomonas aeruginosa is a human pathogen and therefore unacceptable as an industrial organism. A number of other non-pathogenic bacterial producers of rhamnolipid have been identified and these are currently being intensively researched.  All these bacteria yield a mixture of mono-rhamnolipids and di-rhamnolipids in different proportions since the mono form provides the substrate for a second rhamnosyltransferase to add the second sugar molecule to produce the di form.

It is this second rhamnosyltransferase that will form the focus for this project since it controls the proportion of mono to di-rhamnolipid in the final product. The approach in this project will be to use our existing knowledge of the gene sequences of this enzyme from different organisms to give heterologous expression in E.coli  of a his-tagged protein which can then be purified. Having a purified enzyme will allow protein sequencing to be carried out by mass spectrometry and the development of a cell free enzyme assay to determine the kinetics of each of the rhamnosyltransferases.

Applicants should note that Bench fees of £2000.00 are required.

Related references:

V. U. Irorere, L. Tripathi, R. Marchant, S. McClean and I. M. Banat (2017). Microbial Rhamnolipid Production: A Critical Re-evaluation of Published Data and Suggested Future Publication Criteria. Applied Microbiology & Biotechnology. 101:3941–3951.   DOI 10.1007/s00253-017-8262-0

Dulcey, Carlos Eduardo; de los Santos, Yossef Lopez); Deziel, Eric ; Doucet, Nicolas. (2017). Semi-rational evolution of the Pseudomonas aeruginosa Rhamnosyltransferase 1 subunit A (RhlA) for the synthesis of industrially relevant rhamnolipids. Protein Science,  26:  68-68.


Essential criteria

  • Upper Second Class Honours (2:1) Degree or equivalent from a UK institution (or overseas award deemed to be equivalent via UK NARIC)


Funding

This is a self-funded PhD opportunity.


Other information


The Doctoral College at Ulster University


Reviews

My experience has been great and the people that I have worked with have been amazing

Kieran O'Donnell - 3D printing of biological cells for tissue engineering applications

Watch Video  

Completing the MRes provided me with a lot of different skills, particularly in research methods and lab skills.

Michelle Clements Clements - MRes - Life and Health Sciences

Watch Video  

Throughout my PhD I’ve been provided with continuous support and guidance by my supervisors and the staff at the University.I’ve also received many opportunities to further enhance my professional development in the form of teaching experience and presenting my work at conferences which will aid in my pursuit of a career in academia or industry.

William Crowe


Key dates

Submission deadline
Tuesday 1 September 2020

Interview Date
To be confirmed


Applying

Apply Online


Contact supervisor

Professor Ibrahim Banat


Other supervisors

Related Funded Opportunities in: Biomedical Sciences ,

Diabetes

Subject:
Biomedical Sciences

 View Details

Genomic Medicine

Subject:
Biomedical Sciences

 View Details

Stratified Medicine

Subject:
Biomedical Sciences

 View Details

The regulation of rhamnolipid biosynthesis in Burkholderia thailandensis.

Closing date:
Tuesday 1 September 2020
Subject:
Biomedical Sciences

 View Details

Optometry and Vision Science

Subject:
Biomedical Sciences

 View Details

MRes in Biomedical Sciences

Subject:
Biomedical Sciences

 View Details

The production of rhamnolipid biosurfactant by Pseudomonas aeruginosa growing in biofilms.

Closing date:
Tuesday 1 September 2020
Subject:
Biomedical Sciences

 View Details

Molecular Pathology of Glaucoma

Closing date:
Wednesday 1 January 2020
Subject:
Biomedical Sciences

 View Details

The design and analysis of a novel photo-activated antimicrobial system

Closing date:
Tuesday 1 September 2020
Subject:
Biomedical Sciences

 View Details